Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability 2026-21670 | Proposed rule | Oct 23 |
Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Availability 2026-21669 | Proposed rule | Oct 23 |
Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026 2026-21420 | Proposed rule | Oct 20 |
Further Reducing Bureaucracy and Burden From the Administration for Native Americans 2026-21004 | Proposed rule | Oct 14 |
Food Additives Permitted in Feed and Drinking Water of Animals; Chromium Propionate 2026-20979 | Final rule | Oct 14 |
Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods 2026-20848 · significant | Final rule | Oct 13 |
Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens 2026-20727 | Final rule | Oct 9 |
Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use 2026-20726 | Final rule | Oct 9 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit 2026-20725 | Final rule | Oct 9 |
Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; Availability 2026-20721 | Proposed rule | Oct 9 |
Removal of Obsolete Portion of Regulation Relating to Care and Treatment of Ineligible Individuals 2026-20685 | Final rule | Oct 8 |
Removal of Obsolete/Suspended Regulations 2026-20684 | Final rule | Oct 8 |
Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes 2026-20613 | Proposed rule | Oct 8 |
Medical Devices; Exemptions From Premarket Notification: Class II Devices; Certain Clinical Toxicology Test Systems 2026-20448 | Final rule | Oct 6 |
Transparency in Coverage 2026-20447 · significant | Final rule | Oct 6 |
Medical Devices; Immunology and Microbiology Devices; Classification of the High Throughput DNA Sequencing for Hereditary Cancer Predisposition Assessment Test System 2026-20443 | Final rule | Oct 6 |
Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry 2026-20441 | Final rule | Oct 6 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Focused Ultrasound System for Non-Thermal, Mechanical Tissue Ablation 2026-20440 | Final rule | Oct 6 |
Reforming Federal Reporting and Assessments in Child Welfare 2026-20329 | Proposed rule | Oct 5 |
Global Benchmark for Efficient Drug Pricing (GLOBE) Model 2026-20281 · significant | Final rule | Oct 2 |
Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update; Correction 2026-20134 | Final rule | Oct 1 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program; Correction 2026-20131 | Final rule | Oct 1 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Flushing and Storage Solution for Vascular Autografts at Room Temperature 2026-20075 | Final rule | Sep 30 |
Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements; Correction 2026-20067 | Final rule | Sep 30 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027; Correction 2026-19959 | Final rule | Sep 30 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards; Correction 2026-19946 · significant | Final rule | Sep 29 |
Filing of Color Additive Petition From Doehler GmbH; Request To Amend the Color Additive Regulations To Provide for the Safe Use of Calcium Sulfate in Various Foods at Levels Consistent With Good Manufacturing Practice 2026-19658 | Proposed rule | Sep 25 |
Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D2 Inactive Bakers Yeast 2026-19656 | Final rule | Sep 25 |
Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards 2026-19535 | Proposed rule | Sep 24 |
Patient Protection and Affordable Care Act; Temporary Moratoria on Certain Agent and Broker Registration To Participate in the Exchanges 2026-19493 | Final rule | Sep 23 |
Nonclinical Testing Terminology 2026-19350 | Final rule | Sep 22 |
Nonclinical Testing Terminology 2026-19349 | Proposed rule | Sep 22 |
Medical Devices; Exemption From Premarket Notification: Radiology Computer-Aided Detection and/or Diagnosis Devices and Computer-Aided Triage and Notification Devices 2026-19074 | Final rule | Sep 17 |
Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software 2026-18612 | Final rule | Sep 11 |
Green Innovation GmbH; Withdrawal of Food Additive Petition (Animal Use) 2026-18469 | Proposed rule | Sep 10 |
Medical Devices; Cardiovascular Devices; Classification of the Mechanical Deviation Device for Esophageal Protection During Cardiac Ablation Procedures 2026-18433 | Final rule | Sep 10 |
Medical Devices; Cardiovascular Devices; Classification of the Temperature Regulation Device for Esophageal Protection During Cardiac Ablation Procedures 2026-18432 | Final rule | Sep 10 |
Medical Devices; Cardiovascular Devices; Classification of the Extravascular Support for an Arteriovenous Fistula for Vascular Access 2026-18431 | Final rule | Sep 10 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease 2026-18430 | Final rule | Sep 10 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Cooperative Powered Surgical Assist Device for ENT Surgery 2026-18429 | Final rule | Sep 10 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device 2026-18428 | Final rule | Sep 10 |
Medical Devices; Radiology Devices; Classification of the Vaginal Hydrogel Packing System 2026-18427 | Final rule | Sep 10 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Whole Room Microbial Reduction Device 2026-18426 | Final rule | Sep 10 |
Reducing Bureaucracy and Burden for the Repatriation of Mentally Ill Nationals 2026-18167 | Proposed rule | Sep 4 |
Federal Independent Dispute Resolution Operations; Correction 2026-17622 · significant | Final rule | Aug 28 |
Gardenia Blue Interest Group; Filing of Color Additive Petition 2026-16944 | Proposed rule | Aug 19 |
International Association of Color Manufacturers; Filing of Color Additive Petition 2026-16943 | Proposed rule | Aug 19 |
Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate 2026-16942 | Final rule | Aug 19 |
GNT USA, LLC.; Filing of Color Additive Petition 2026-16939 | Proposed rule | Aug 19 |
Medical Devices; Classification of Accessories Distinct From Other Devices; Proposed List of Accessories Suitable for Class I; Request for Comments 2026-16729 | Proposed rule | Aug 17 |
Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer 2026-16728 | Proposed rule | Aug 17 |
Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product 2026-16727 | Final rule | Aug 17 |
Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children 2026-16508 | Final rule | Aug 13 |
Guide To Minimize Biological Hazards in Ready-to-Eat Fresh-Cut Produce; Guidance for Industry; Availability 2026-16420 | Final rule | Aug 12 |
Adoption and Foster Care Analysis and Reporting System 2026-16414 · significant | Proposed rule | Aug 12 |
Substances Generally Recognized as Safe 2026-16296 · significant | Proposed rule | Aug 11 |
Radiology Devices; Reclassification of Digital Breast Tomosynthesis System 2026-16209 | Proposed rule | Aug 10 |
Reducing Federal Burden for Head Start Programs 2026-16134 | Proposed rule | Aug 7 |
Medical Devices; Radiology Devices; Classification of the Fludeoxyglucose F18-Guided Radiation Therapy System 2026-15963 | Final rule | Aug 6 |
Micro-Tracers, Inc.; Response to Objections and Requests for a Public Hearing 2026-15920 | Final rule | Aug 5 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards 2026-15833 | Final rule | Aug 4 |
Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements 2026-15686 | Final rule | Aug 3 |
Reducing Bureaucracy and Burden in Family Violence and Prevention Services 2026-15681 | Final rule | Aug 3 |
Modification of Certain Terminology in Title 21; Reopening of the Comment Period 2026-15671 | Proposed rule | Aug 3 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program 2026-15652 | Final rule | Aug 3 |
Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update 2026-15588 | Final rule | Jul 31 |
Reducing Bureaucracy and Burden for Family Assistance Programs 2026-15567 | Final rule | Jul 31 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027 2026-15562 | Final rule | Jul 31 |
Medicare Program; Updates to the Master List of Items Potentially Subject to Face-to-Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior Authorization List 2026-15446 | Final rule | Jul 30 |
Administrative Costs for Children in Title IV-E Foster Care 2026-15403 · significant | Proposed rule | Jul 30 |
Medical Devices; Radiology Devices; Classification of the Phase-Changing Fiducial Marker for Radiation Therapy 2026-15303 | Final rule | Jul 29 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Active Noise Attenuation System for Infant Incubators 2026-15075 | Final rule | Jul 27 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Non-Medicated Topical Formulation for Treatment of Erectile Dysfunction 2026-15074 | Final rule | Jul 27 |
Evonik Corporation, Filing of Food Additive Petition (Animal Use) 2026-15021 | Proposed rule | Jul 24 |
Rescinding Portions of the U.S. Department of Health and Human Services Title VI Regulations To Align With the Statutory Text and Conform to Executive Order 14281 2026-15000 | Final rule | Jul 24 |
Medical Devices; Orthopedic Devices; Classification of the Intraoperative Surgical Angle Measurement Tool 2026-14987 | Final rule | Jul 24 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Diabetes Digital Behavioral Therapeutic Device 2026-14986 | Final rule | Jul 24 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Over-the-Counter Test To Detect SARS-CoV-2 From Clinical Specimens 2026-14985 | Final rule | Jul 24 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression 2026-14984 | Final rule | Jul 24 |
Revocation of the Color Additive Listing for Use of Orange B on Casings or Surfaces of Frankfurters and Sausages 2026-14910 | Final rule | Jul 23 |
Proposal To Revoke the Color Additive Listing for Use of Citrus Red No. 2 on the Skins of Mature Oranges 2026-14909 | Proposed rule | Jul 23 |
Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes 2026-14897 | Proposed rule | Jul 23 |
Rescinding Guidelines for Eliminating Discrimination and Denial of Services on the Basis of Race, Color, National Origin, Sex, and Handicap in Vocational Education Programs 2026-14893 | Final rule | Jul 23 |
Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction 2026-14709 · significant | Final rule | Jul 21 |
Food Standards of Identity Modernization; Pasteurized Orange Juice 2026-14573 | Final rule | Jul 20 |
Request for Information; Clinical Laboratory Improvement Amendments of 1988 (CLIA) Regulations 2026-14358 | Proposed rule | Jul 16 |
Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program 2026-14327 | Proposed rule | Jul 16 |
Designated Placement Requirements Under Titles IV-E and IV-B for LGBTQI+ Children; Rescission 2026-14131 | Final rule | Jul 14 |
Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments 2026-14073 · significant | Proposed rule | Jul 13 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor 2026-13716 | Final rule | Jul 7 |
Recission of the National Cancer Institute Clinical Cancer Education Program Regulation 2026-13711 | Proposed rule | Jul 7 |
Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots 2026-13656 | Proposed rule | Jul 7 |
Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies 2026-13602 | Proposed rule | Jul 6 |
Reducing Bureaucracy and Burden for Children, Youth, and Family Programs 2026-13451 | Final rule | Jul 2 |
Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation 2026-13140 | Final rule | Jun 30 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis 2026-13139 | Final rule | Jun 30 |
Medicaid Program; Community Engagement Requirement for Certain Individuals C1-2026-11094 | Final rule | Jun 29 |
Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber 2026-13101 | Final rule | Jun 29 |
Establishment Registration and Product Listing for Tobacco Products 2026-13047 · significant | Proposed rule | Jun 29 |
Unaccompanied Children Program Foundational Rule; Sponsor Assessment Update To Include Proof of Identity, Background Check, Placement, and Income Verification Standards 2026-12946 | Proposed rule | Jun 26 |
Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program 2026-12925 | Proposed rule | Jun 26 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep System 2026-12905 | Final rule | Jun 26 |
Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs Syndrome 2026-12904 | Final rule | Jun 26 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Breast Implant Suction Retrieval System 2026-12903 | Final rule | Jun 26 |
Medical Devices; Immunology and Microbiology Devices; Classification of the SARS-CoV-2 Serology Test 2026-12902 | Final rule | Jun 26 |
Medical Devices; Neurological Devices; Classification of the Computerized Behavioral Therapy Device for the Treatment of Fibromyalgia Symptoms 2026-12901 | Final rule | Jun 26 |
Medical Devices; Clinical Chemistry and Toxicology Devices; Classification of the Prognostic Test for Development or Progression of Preeclampsia 2026-12900 | Final rule | Jun 26 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Foam or Gel Chemical Sterilant/High Level Disinfectant 2026-12899 | Final rule | Jun 26 |
Sterigenics U.S., LLC; Filing of Food Additive Petition 2026-12855 | Proposed rule | Jun 25 |
Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP 2026-12676 | Proposed rule | Jun 24 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Traction Device 2026-12445 | Final rule | Jun 22 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Light-Projecting Measuring Device 2026-12444 | Final rule | Jun 22 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Simple In Vitro Diagnostic Device for the Detection of Secreted Proteins From Bacillus Species (spp.) in Human Clinical Samples 2026-12443 | Final rule | Jun 22 |
Request for Information (RFI): Pharmacy Benefit Manager Compensation and Data Collection 2026-12344 | Proposed rule | Jun 18 |
Reducing Bureaucracy and Burden for Native American Programs 2026-12324 | Final rule | Jun 18 |
Reducing Bureaucracy and Burden for Child Support Enforcement Programs 2026-12295 | Proposed rule | Jun 18 |
Reducing Bureaucracy and Burden for Human Services and Emergency Response Programs-Repatriation Program 2026-12189 | Final rule | Jun 17 |
Medical Devices; Radiology Devices; Classification of the Radiological Machine Learning-Based Quantitative Imaging Software With Predetermined Change Control Plan 2026-12166 | Final rule | Jun 17 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule 2026-12165 | Final rule | Jun 17 |
Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions 2026-12069 · significant | Final rule | Jun 16 |
Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program 2026-12059 | Proposed rule | Jun 16 |
Amendment and Revocation of Organizational Information Regulations 2026-11998 | Final rule | Jun 15 |
Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard 2026-11994 | Proposed rule | Jun 15 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System 2026-11740 | Final rule | Jun 11 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings 2026-11739 | Final rule | Jun 11 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus 2026-11589 | Final rule | Jun 10 |
Reducing Bureaucracy and Burden for Community Services Programs 2026-11531 | Final rule | Jun 9 |
Employment and Training Services for Noncustodial Parents in the Child Support Program; Rescission 2026-11530 · significant | Proposed rule | Jun 9 |
Medical Devices; Orthopedic Devices; Classification of the Resorbable Calcium Salt Bone Void Filler Containing a Single Approved Aminoglycoside Antibacterial 2026-11308 | Final rule | Jun 5 |
Medical Devices; Orthopedic Devices; Classification of the Shoulder Joint Humeral (Hemi-Shoulder) Ceramic Head/Metallic Stem Cemented or Uncemented Prosthesis 2026-11306 | Final rule | Jun 5 |
Medical Devices; Orthopedic Devices; Classification of the Absorbable Metallic Bone Fixation Fastener 2026-11302 | Final rule | Jun 5 |
Federal Independent Dispute Resolution Operations 2026-11140 · significant | Final rule | Jun 4 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address; Correction 2026-11104 | Final rule | Jun 3 |
Medicaid Program; Community Engagement Requirement for Certain Individuals 2026-11094 | Final rule | Jun 3 |
Notice of Vacatur Regarding Certain Provisions of the 2024 Nondiscrimination in Health Programs and Activities Final Rule 2026-11015 | Final rule | Jun 2 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Rigid Sterilization Container With Electronic Monitoring 2026-10908 | Final rule | Jun 1 |
Medical Devices; Anesthesiology Devices; Classification of the Real-Time Ultrasound Anatomy Visualization and Labeling Device for Ultrasound Guided Regional Anesthesia 2026-10907 | Final rule | Jun 1 |
Medical Devices; Anesthesiology Devices; Classification of the Adjunctive Pain Measurement Device for Anesthesiology 2026-10905 | Final rule | Jun 1 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Orally Ingested Transient Device for Constipation 2026-10904 | Final rule | Jun 1 |
Medical Devices; Dental Devices; Classification of the Intraoral Cooling Device 2026-10899 | Final rule | Jun 1 |
Medical Devices; Hematology and Pathology Devices; Classification of the Von Willebrand Factor Assay 2026-10898 | Final rule | Jun 1 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Oropharyngeal Electrical Stimulator 2026-10894 | Final rule | Jun 1 |
Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model 2026-10890 · significant | Final rule | Jun 1 |
Regulation for Federal Financial Assistance 2026-10817 | Proposed rule | May 29 |
Medical Devices; Neurological Devices; Classification of the Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms 2026-10675 | Final rule | May 29 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Suturing Device for Altering Gastric Anatomy for Weight Loss 2026-10621 | Final rule | May 28 |
Food Additive Petition From Environmental Defense Fund, et al.; Request To Amend the Food Additive Regulations To Remove the Solvents Benzene, Ethylene Dichloride, Methylene Chloride, and Trichloroethylene; Reopening of the Comment Period 2026-10615 | Proposed rule | May 28 |
Color Additive Petition from Environmental Defense Fund, et al.; Request To Amend the Color Additive Regulations To Remove the Solvents Ethylene Dichloride, Methylene Chloride, and Trichloroethylene; Reopening of the Comment Period 2026-10614 | Proposed rule | May 28 |
Control of Communicable Diseases; Foreign Quarantine 2026-10543 | Final rule | May 27 |
Reducing Bureaucracy and Burden for Family Assistance Programs 2026-10401 | Proposed rule | May 26 |
Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments 2026-10292 · significant | Proposed rule | May 22 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; and Other Policy Changes; Correction 2026-10276 | Proposed rule | May 22 |
Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program 2026-10050 · significant | Final rule | May 20 |
Excepted Fertility Benefits 2026-09479 | Proposed rule | May 13 |
Restoring Flexibility To Support Head Start Program Access 2026-09383 · significant | Proposed rule | May 12 |
Restoring Flexibility in the Child Care and Development Fund (CCDF) 2026-09382 · significant | Final rule | May 12 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection 2026-09335 | Final rule | May 12 |
Extension of Compliance Dates for Nondiscrimination on the Basis of Disability; Accessibility of Web Content and Mobile Applications of Recipients of Departmental Financial Assistance 2026-09266 | Final rule | May 11 |
Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse 2026-09152 | Final rule | May 8 |
Modification of Certain Terminology in Title 21 2026-08826 | Proposed rule | May 6 |
Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals 2026-08813 | Final rule | May 6 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device 2026-08812 | Final rule | May 6 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples 2026-08811 | Final rule | May 6 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the Appearance of Acute Post-Surgical Incisions 2026-08497 | Final rule | May 1 |
Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter 2026-08426 | Final rule | Apr 30 |
Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System 2026-08425 | Final rule | Apr 30 |
Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device 2026-08424 | Final rule | Apr 30 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System 2026-07863 | Final rule | Apr 22 |
Medical Devices; Anesthesiology Devices; Classification of the Device for Sleep Apnea Testing Based on Mandibular Movement 2026-07862 | Final rule | Apr 22 |
Medical Devices; Ophthalmic Devices; Classification of the Digital Therapy Device for Amblyopia 2026-07861 | Final rule | Apr 22 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Alzheimer's Disease Pathology Assessment Test 2026-07860 | Final rule | Apr 22 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address 2026-07500 | Final rule | Apr 16 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; and Other Policy Changes; Correction 2026-07470 | Proposed rule | Apr 16 |
Medical Devices; Orthopedic Devices; Classification of the Manual Surgical Instrument for Appropriate Patient Selection for Orthopedic Implant 2026-07367 | Final rule | Apr 16 |
Physical Medicine Devices; Reclassification of Non-Invasive Bone Growth Stimulators 2026-07366 | Final rule | Apr 16 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Transcutaneous Electrical Nerve Stimulator for the Relief of Congestion 2026-07365 | Final rule | Apr 16 |
Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges 2026-07205 · significant | Proposed rule | Apr 14 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; and Other Policy Changes 2026-07203 | Proposed rule | Apr 14 |
Reducing Bureaucracy and Burden for Community Services Programs 2026-06760 | Proposed rule | Apr 8 |
Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update 2026-06675 | Proposed rule | Apr 7 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027 2026-06674 | Proposed rule | Apr 7 |
Reducing Bureaucracy and Burden for Children, Youth, and Family Programs 2026-06646 | Proposed rule | Apr 6 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program 2026-06642 | Proposed rule | Apr 6 |
Reducing Bureaucracy and Burden in Family Violence and Prevention Services 2026-06633 | Proposed rule | Apr 6 |
Work Participation Rate Calculation Changes: Recalibration of the Caseload Reduction Credit and Prohibition of Small Checks in Work Participation Rate Calculation 2026-06632 · significant | Proposed rule | Apr 6 |
Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements 2026-06604 | Proposed rule | Apr 6 |
Medicare Program; Contract Year 2027 and Certain Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program 2026-06600 · significant | Final rule | Apr 6 |
Filing of Color Additive Petition From the International Association of Color Manufacturers; Request To Amend the Color Additive Regulations To Remove the Solvents Methylene Chloride, Trichloroethylene, and Ethylene Dichloride 2026-06295 | Proposed rule | Apr 1 |
Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests 2026-06064 | Proposed rule | Mar 30 |
Reducing Bureaucracy and Burden for Refugee Resettlement Programs 2026-06027 | Final rule | Mar 27 |
Reducing Bureaucracy and Burden for Human Services and Emergency Response Programs-Repatriation Program 2026-05997 | Proposed rule | Mar 27 |
Reducing Bureaucracy and Burden for Native American Programs 2026-05994 | Proposed rule | Mar 27 |
General and Plastic Surgery Devices; Reclassification of Optical Diagnostic Devices for Melanoma Detection and Electrical Impedance Spectrometers, To Be Renamed Software-Aided Adjunctive Diagnostic Devices for Use on Skin Lesions by Physicians Trained in the Diagnosis and Management of Skin Cancer 2026-05772 | Final rule | Mar 25 |
Listing of Color Additive Exempt From Certification; Spirulina Extract; Delay of Effective Date 2026-05733 | Final rule | Mar 24 |
Listing of Color Additive Exempt From Certification; Beetroot Red; Delay of Effective Date 2026-05732 | Final rule | Mar 24 |
Administrative Simplification; Adoption of Standards for Health Care Claims Attachments Transactions and Electronic Signatures 2026-05676 · significant | Final rule | Mar 24 |
Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended To Prevent Metastasis 2026-05322 | Proposed rule | Mar 18 |
Medical Devices; Radiology Devices; Classification of Blood Irradiators 2026-05320 | Proposed rule | Mar 18 |
General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; Withdrawal of Proposed Rule 2026-05103 | Proposed rule | Mar 16 |
Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels 2026-04981 | Final rule | Mar 13 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction 2026-04797 · significant | Final rule | Mar 12 |
Designated Placement Requirements Under Titles IV-E and IV-B for LGBTQI+ Children; Rescission 2026-04515 | Proposed rule | Mar 6 |
Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction 2026-04467 · significant | Proposed rule | Mar 6 |
Revising the National Drug Code Format and Drug Label Barcode Requirements 2026-04368 | Final rule | Mar 5 |
Ecoflora Cares; Filing of Color Additive Petition 2026-04288 | Proposed rule | Mar 4 |
Kemin Industries, Inc.; Filing of Food Additive Petition (Animal Use) 2026-04284 | Proposed rule | Mar 4 |
Request for Information (RFI) Related to Comprehensive Regulations To Uncover Suspicious Healthcare (CRUSH) 2026-03968 | Proposed rule | Feb 27 |
Private Health Insurance; Transparency in Coverage; Extension of Comment Period 2026-03798 · significant | Proposed rule | Feb 25 |
Managed Care 2026-03779 | Final rule | Feb 25 |
Medicare Program; Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Rating; Hospital Price Transparency; and Notice of Closure of a Teaching Hospital and Opportunity To Apply for Available Slots; Correction 2026-03578 · significant | Final rule | Feb 23 |
Medications for the Treatment of Opioid Use Disorder; Correction 2026-03577 · significant | Final rule | Feb 23 |
Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community 2026-03286 | Final rule | Feb 19 |
Revocation of Methods of Analysis Regulation 2026-03285 | Final rule | Feb 19 |
Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program 2026-02769 · significant | Proposed rule | Feb 11 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor; Change of Sponsor Address 2026-02331 | Final rule | Feb 6 |
Listing of Color Additives Exempt From Certification; Spirulina Extract 2026-02314 | Final rule | Feb 6 |
Listing of Color Additives Exempt From Certification; Beetroot Red 2026-02313 | Final rule | Feb 6 |
Medicaid Program; Preserving Medicaid Funding for Vulnerable Populations-Closing a Health Care-Related Tax Loophole 2026-02040 · significant | Final rule | Feb 2 |
Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance 2026-02038 | Proposed rule | Feb 2 |
Request for Information: Diagnostic Imaging Interoperability Standards and Certification 2026-01866 | Proposed rule | Jan 30 |
Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage 2026-01833 · significant | Proposed rule | Jan 30 |
Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP 2026-01817 | Proposed rule | Jan 29 |
Medicare Program; Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals 2026-01730 · significant | Proposed rule | Jan 29 |
Annual Civil Monetary Penalties Inflation Adjustment 2026-01688 | Final rule | Jan 28 |
Tribal Consultation on Proposed Modifications to the HIPAA Privacy Rule 2026-00561 | Proposed rule | Jan 14 |
Medicare Program; Updates to the Master List of Items Potentially Subject to Face to Face Encounter and Written Order Prior to Delivery and/or Prior Authorization Requirements; Updates to the Required Face-to-Face Encounter and Written Order Prior to Delivery List; and Updates to the Required Prior Authorization List 2026-00487 | Final rule | Jan 13 |
Restoring Flexibility in the Child Care and Development Fund (CCDF) 2025-24272 · significant | Proposed rule | Jan 5 |
Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications 2025-24123 · significant | Final rule | Dec 31, 2025 |
Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions To Unleash Prosperity 2025-23896 · significant | Proposed rule | Dec 29, 2025 |
Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability; Withdrawal 2025-23890 · significant | Proposed rule | Dec 29, 2025 |
Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model 2025-23705 | Proposed rule | Dec 23, 2025 |
Global Benchmark for Efficient Drug Pricing (GLOBE) Model 2025-23702 · significant | Proposed rule | Dec 23, 2025 |
Transparency in Coverage 2025-23693 · significant | Proposed rule | Dec 23, 2025 |
Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance 2025-23484 | Proposed rule | Dec 19, 2025 |
Medicare and Medicaid Programs; Hospital Condition of Participation: Prohibiting Sex-Rejecting Procedures for Children 2025-23465 | Proposed rule | Dec 19, 2025 |
Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children 2025-23464 | Proposed rule | Dec 19, 2025 |
COVID-19 Mitigation Policy Requirement in Head Start Programs; Recission 2025-23452 · significant | Final rule | Dec 19, 2025 |
Medical Devices; Neurological Devices; Classification of the Electrical Tongue Nerve Stimulator To Treat Motor Deficits 2025-23413 | Final rule | Dec 19, 2025 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program; Correction 2025-23081 · significant | Final rule | Dec 17, 2025 |
Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model 2025-22543 · significant | Proposed rule | Dec 11, 2025 |
Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts 2025-22327 | Proposed rule | Dec 9, 2025 |
Expiration of Interim Final Rule: Control of Communicable Diseases; Foreign Quarantine 2025-21962 · significant | Final rule | Dec 4, 2025 |
Medical Devices; Quality Management System Regulation Technical Amendments 2025-21955 | Final rule | Dec 4, 2025 |
Medicare and Medicaid Programs; Repeal of Minimum Staffing Standards for Long-Term Care Facilities 2025-21792 | Final rule | Dec 3, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies 2025-21767 · significant | Final rule | Dec 2, 2025 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction 2025-21458 · significant | Final rule | Nov 28, 2025 |
Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program 2025-21456 · significant | Proposed rule | Nov 28, 2025 |
Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal 2025-21407 · significant | Proposed rule | Nov 28, 2025 |
Green Innovation GmbH; Filing of Food Additive Petition (Animal Use) 2025-21226 | Proposed rule | Nov 26, 2025 |
Medical Devices; Neurological Devices; Classification of Field Generator Positioning Device 2025-21218 | Final rule | Nov 26, 2025 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Anchored Esophageal Sheath 2025-21217 | Final rule | Nov 26, 2025 |
Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order; Request for Comments 2025-21071 | Proposed rule | Nov 25, 2025 |
Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Rating; Hospital Price Transparency; and Notice of Closure of a Teaching Hospital and Opportunity To Apply for Available Slots 2025-20907 · significant | Final rule | Nov 25, 2025 |
Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model 2025-20681 · significant | Final rule | Nov 24, 2025 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program 2025-19787 · significant | Final rule | Nov 5, 2025 |
Listing of Color Additives Exempt From Certification; Gardenia (Genipin) Blue; Confirmation of Effective Date 2025-19166 | Final rule | Oct 1, 2025 |
Revocation of Food Standards for 11 Products Not Currently Sold; Confirmation of Effective Date 2025-18730 | Final rule | Sep 26, 2025 |
Prior Notice: Adding Requirement To Submit Mail Tracking Number for Articles of Food Arriving by International Mail and Timeframe for Post-Refusal and Post-Hold Submissions 2025-18655 | Final rule | Sep 25, 2025 |
Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur 2025-18239 | Final rule | Sep 19, 2025 |
Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (PACE)-Finalization of Format Provider Directories for Medicare Plan Finder 2025-18236 · significant | Final rule | Sep 19, 2025 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address; Correction 2025-18217 | Final rule | Sep 19, 2025 |
Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices 2025-18082 | Final rule | Sep 18, 2025 |
Radiological Health Regulations; Technical Amendments 2025-18080 | Final rule | Sep 18, 2025 |
Proposal To Remove the Color Additive Listing for Use of Orange B on Casings or Surfaces of Frankfurters and Sausages 2025-18023 | Proposed rule | Sep 17, 2025 |
Standards of Conduct; Revocation of Superseded Regulations; Revision of Residual Provisions; Correction 2025-17237 | Final rule | Sep 8, 2025 |
Medicare Program; FY 2026 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements; Correction 2025-16960 · significant | Final rule | Sep 4, 2025 |
Food Additives Permitted for Direct Addition to Food for Human Consumption; Vitamin D3 in Yogurt and Other Cultured Dairy Products Fermented With Lactobacillus delbrueckii, Subspecies bulgaricus, and Streptococcus thermophilus 2025-16946 | Final rule | Sep 4, 2025 |
Secondary Direct Food Additives Permitted in Food for Human Consumption; Hydrogen Peroxide 2025-16898 | Final rule | Sep 3, 2025 |
Biomin GmbH; Filing of Food Additive Petition (Animal Use) 2025-16859 | Proposed rule | Sep 3, 2025 |
Advisory Committee; Arthritis Advisory Committee; Termination; Removal From List of Standing Committees 2025-16629 | Final rule | Aug 29, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies C3-2025-12347 · significant | Proposed rule | Aug 28, 2025 |
Terminating National Institutes of Health Minority Biomedical Research Support Program and Rescinding the Program's Related Regulation 2025-16321 | Final rule | Aug 26, 2025 |
Standards of Conduct; Revocation of Superseded Regulations; Revision of Residual Provisions 2025-16129 | Final rule | Aug 22, 2025 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address 2025-16079 | Final rule | Aug 22, 2025 |
Listing of Color Additives Exempt From Certification; Calcium Phosphate; Confirmation of Effective Date 2025-16047 | Final rule | Aug 21, 2025 |
Listing of Color Additives Exempt From Certification; Galdieria Extract Blue; Confirmation of Effective Date 2025-16046 | Final rule | Aug 21, 2025 |
Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract; Confirmation of Effective Date 2025-16045 | Final rule | Aug 21, 2025 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Laparoscopic Gastrointestinal Sizing Tool 2025-16041 | Final rule | Aug 21, 2025 |
Medical Devices; Orthopedic Devices; Classification of Orthopedic Manual Surgical Instrumentation for Use With Non-Fusion Spinous Process Spacer Devices 2025-16040 | Final rule | Aug 21, 2025 |
Medical Devices; Orthopedic Devices; Classification of Orthopedic Manual Surgical Instrumentation for Use With Total Disc Replacement Devices 2025-16039 | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Mutation Detection Test for Myeloproliferative Neoplasms 2025-16038 | Final rule | Aug 21, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Pharmacogenetic Assessment System 2025-16037 | Final rule | Aug 21, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Menopause Test System 2025-16036 | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Cancer Predisposition Risk Assessment System 2025-16035 | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of A Multiplex Respiratory Panel To Detect and Identify Emerging Respiratory Pathogen(s) and Common Respiratory Pathogens in Human Clinical Specimens 2025-16034 | Final rule | Aug 21, 2025 |
Medical Devices; Radiology Devices; Classification of the Liver Iron Concentration Imaging Companion Diagnostic for Deferasirox 2025-16033 | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Postnatal Chromosomal Copy Number Variation Detection System 2025-16032 | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Anti-Phospholipase A2 Receptor Immunological Test System 2025-16031 | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device That Detects Nucleic Acid Sequences From Microorganisms Associated With Vaginitis and Bacterial Vaginosis 2025-16030 | Final rule | Aug 21, 2025 |
Administrative Simplification: Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA), National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard; Updates to Compliance and Other Related Dates 2025-15958 | Final rule | Aug 21, 2025 |
Evonik Corporation; Filing of Food Additive Petition (Animal Use) 2025-15792 | Proposed rule | Aug 19, 2025 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction 2025-15492 · significant | Proposed rule | Aug 14, 2025 |
Food Standards of Identity Modernization; Pasteurized Orange Juice; Proposed Rule; Correction 2025-15473 | Proposed rule | Aug 14, 2025 |
Requirements for Additional Traceability Records for Certain Foods: Compliance Date Extension 2025-14967 | Proposed rule | Aug 7, 2025 |
Food Standards of Identity Modernization; Pasteurized Orange Juice 2025-14949 | Proposed rule | Aug 6, 2025 |
Listing of Color Additives Exempt From Certification; Gardenia (Genipin) Blue; Correction 2025-14905 | Final rule | Aug 6, 2025 |
Medicare Program; FY 2026 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements 2025-14782 · significant | Final rule | Aug 5, 2025 |
Medicare Program; FY 2026 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update 2025-14781 · significant | Final rule | Aug 5, 2025 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program 2025-14780 · significant | Final rule | Aug 5, 2025 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2026 Rates; Changes to the FY 2025 IPPS Rates Due to Court Decision; Requirements for Quality Programs; and Other Policy Changes; Health Data, Technology, and Interoperability: Electronic Prescribing, Real-Time Prescription Benefit and Electronic Prior Authorization 2025-14681 | Final rule | Aug 4, 2025 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2026 2025-14679 · significant | Final rule | Aug 4, 2025 |
Spoonbill Foundation; Filing of Food Additive Petition 2025-14339 | Proposed rule | Jul 29, 2025 |
APIX Biosciences US LLC; Filing of Food Additive Petition (Animal Use) 2025-14335 | Proposed rule | Jul 29, 2025 |
Regulatory Hearing Before the Food and Drug Administration 2025-14203 | Final rule | Jul 28, 2025 |
Proposal To Revoke 18 Standards of Identity for Dairy Products 2025-13424 | Proposed rule | Jul 17, 2025 |
Revocation of Food Standards for 11 Products Not Currently Sold 2025-13423 | Proposed rule | Jul 17, 2025 |
Revocation of Food Standards for 11 Products Not Currently Sold 2025-13421 | Final rule | Jul 17, 2025 |
Proposal To Revoke 23 Standards of Identity for Foods 2025-13420 | Proposed rule | Jul 17, 2025 |
Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Ratings; and Hospital Price Transparency 2025-13360 · significant | Proposed rule | Jul 17, 2025 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program 2025-13271 · significant | Proposed rule | Jul 16, 2025 |
Listing of Color Additives Exempt From Certification; Gardenia (Genipin) Blue 2025-13175 | Final rule | Jul 15, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies C2-2025-12347 · significant | Proposed rule | Jul 11, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies C1-2025-12347 · significant | Proposed rule | Jul 9, 2025 |
Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model 2025-12368 · significant | Proposed rule | Jul 2, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies 2025-12347 · significant | Proposed rule | Jul 2, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Muscular Dystrophy Newborn Screening Test 2025-11796 | Final rule | Jun 26, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections 2025-11794 | Final rule | Jun 26, 2025 |
Medical Devices; Hematology and Pathology Devices; Classification of the Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities From Patients With Hematologic Malignancies 2025-11793 | Final rule | Jun 26, 2025 |
Medical Devices; Radiology Devices; Classification of the Cream for X-Ray Attenuation 2025-11791 | Final rule | Jun 26, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Lysosomal Storage Disorder Newborn Screening Test System 2025-11781 | Final rule | Jun 26, 2025 |
Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability 2025-11606 | Final rule | Jun 25, 2025 |
Medical Devices; Exemptions From Premarket Notification: Class II Devices; Clinical Electronic Thermometers 2025-11207 | Final rule | Jun 18, 2025 |
Medical Devices; Radiology Devices; Classification of the Radiological Computer-Assisted Detection and Diagnosis Software 2025-10789 | Final rule | Jun 13, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Clinical Mass Spectrometry Microorganism Identification and Differentiation System 2025-10788 | Final rule | Jun 13, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Cellular Analysis System for Multiplexed Antimicrobial Susceptibility Testing 2025-10787 | Final rule | Jun 13, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Fungal Nucleic Acids Directly in Respiratory Specimens 2025-10786 | Final rule | Jun 13, 2025 |
Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product 2025-10549 | Proposed rule | Jun 11, 2025 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2026 Rates; Requirements for Quality Programs; and Other Policy Changes; Correction 2025-10261 · significant | Proposed rule | Jun 5, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect Bacterial Protease Activity in Chronic Wound Fluid 2025-09883 | Final rule | Jun 2, 2025 |
Request for Information Regarding the Prescription Drug Machine-Readable File Requirement in the Transparency in Coverage Final Rule 2025-09858 · significant | Proposed rule | Jun 2, 2025 |
Medical Devices; Radiology Devices; Classification of the Radiological Acquisition and/or Optimization Guidance System 2025-09837 | Final rule | Jun 2, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Mullerian Hormone Test System 2025-09776 | Final rule | May 30, 2025 |
Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Correction 2025-09695 · significant | Final rule | May 29, 2025 |
Listing of Color Additives; Myoglobin; Confirmation of Effective Date 2025-09680 | Final rule | May 29, 2025 |
Establishing Sanitation Programs for Low-Moisture Ready-to-Eat Human Foods and Taking Corrective Actions Following a Pathogen Contamination Event: Draft Guidance for Industry; Reopening of Comment Period 2025-09653 | Proposed rule | May 29, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Inherited Nucleotide Repeat Disorder Deoxyribonucleic Acid Test 2025-09641 | Final rule | May 29, 2025 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Temporarily-Placed Urethral Opening System for Symptoms of Benign Prostatic Hyperplasia 2025-09640 | Final rule | May 29, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Zika Virus Serological Reagents 2025-09639 | Final rule | May 29, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Plazomicin Test System 2025-09638 | Final rule | May 29, 2025 |
World Trade Center (WTC) Health Program; Expanded Eligibility for Pentagon and Shanksville, Pennsylvania Responders 2025-09411 | Final rule | May 27, 2025 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2026 C1-2025-06348 · significant | Proposed rule | May 21, 2025 |
Medicare Program; FY 2026 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements C1-2025-06317 · significant | Proposed rule | May 21, 2025 |
Food Additives Permitted in Feed and Drinking Water of Animals; Selenium 2025-08864 | Final rule | May 19, 2025 |
Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments; and Appeal Rights for Certain Changes in Patient Status; Corrections and Correcting Amendment 2025-08676 | Final rule | May 16, 2025 |
Medicaid Program; Preserving Medicaid Funding for Vulnerable Populations-Closing a Health Care-Related Tax Loophole Proposed Rule 2025-08566 · significant | Proposed rule | May 15, 2025 |
Notification of HHS Documents Identified for Rescission 2025-08393 | Final rule | May 14, 2025 |
Listing of Color Additives Exempt From Certification; Galdieria Extract Blue 2025-08250 | Final rule | May 12, 2025 |
Listing of Color Additives Exempt From Certification; Calcium Phosphate 2025-08249 | Final rule | May 12, 2025 |
Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract 2025-08248 | Final rule | May 12, 2025 |
Food Labeling: Front-of-Package Nutrition Information; Extension of Comment Period 2025-08204 · significant | Proposed rule | May 9, 2025 |
Medical Devices; Hematology and Pathology Devices; Classification of the Coagulation System for the Measurement of Whole Blood Viscoelastic Properties in Perioperative Patients 2025-08151 | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microbial Nucleic Acids by Fluorescence In Situ Hybridization in Clinical Specimens 2025-08150 | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect Nucleic Acids From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections and Associated Resistance Marker(s) 2025-08149 | Final rule | May 9, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Voriconazole Test System 2025-08148 | Final rule | May 9, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Breast Milk Macronutrients Test System 2025-08147 | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Cytomegalovirus Nucleic Acid Detection Device for Congenital Cytomegalovirus Infection 2025-08146 | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Microbial Nucleic Acid Storage and Stabilization Device 2025-08145 | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Measure Non-Microbial Analytes To Aid in the Detection and Identification of Localized Human Infections 2025-08144 | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the DNA-Based Test To Measure Minimal Residual Disease in Hematological Malignancies 2025-08143 | Final rule | May 9, 2025 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor 2025-08137 | Final rule | May 9, 2025 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2026 2025-06348 · significant | Proposed rule | Apr 30, 2025 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program 2025-06336 · significant | Proposed rule | Apr 30, 2025 |
Medicare Program; FY 2026 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements 2025-06317 · significant | Proposed rule | Apr 30, 2025 |
Medicare Program; FY 2026 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update 2025-06298 · significant | Proposed rule | Apr 30, 2025 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2026 Rates; Requirements for Quality Programs; and Other Policy Changes 2025-06271 · significant | Proposed rule | Apr 30, 2025 |
Name Change From Office of Child Support Enforcement to Office of Child Support Services; Withdrawal 2025-06958 | Final rule | Apr 23, 2025 |
Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly 2025-06008 · significant | Final rule | Apr 15, 2025 |
Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance; Clarification 2025-06127 | Final rule | Apr 11, 2025 |
Nonprescription Drug Product With an Additional Condition for Nonprescription Use 2025-04978 · significant | Final rule | Mar 25, 2025 |
Unaccompanied Children Program Foundational Rule; Update To Accord With Statutory Requirements 2025-04971 | Final rule | Mar 25, 2025 |
Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients 2025-05007 · significant | Final rule | Mar 24, 2025 |
Privacy Act; Implementation; Further Delay of Effective Date 2025-04979 | Final rule | Mar 24, 2025 |
Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability 2025-04083 | Proposed rule | Mar 19, 2025 |
Impossible Foods, Inc.; Filing of Color Additive Petition 2025-04034 | Proposed rule | Mar 14, 2025 |
Policy on Adhering to the Text of the Administrative Procedure Act 2025-03300 | Final rule | Mar 3, 2025 |
Name Change From Office of Child Support Enforcement to Office of Child Support Services; Reopening of Comment Period and Delaying Effective Date 2025-03147 | Final rule | Feb 27, 2025 |
Food Labeling: Nutrient Content Claims; Definition of Term “Healthy” 2025-03118 | Final rule | Feb 25, 2025 |
Privacy Act; Implementation 2025-02810 | Final rule | Feb 19, 2025 |
Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients 2025-02793 · significant | Final rule | Feb 19, 2025 |
Exchange Establishment Standards and Other Related Standards Under the Affordable Care Act 2025-02715 | Final rule | Feb 14, 2025 |
Administrative Simplification: Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA) National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard; Delay of Effective Date 2025-02511 | Final rule | Feb 11, 2025 |
Privacy Act; Implementation 2025-02158 | Final rule | Feb 3, 2025 |
Nonprescription Drug Product With an Additional Condition for Nonprescription Use 2025-01840 · significant | Final rule | Jan 27, 2025 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address 2025-01226 | Final rule | Jan 21, 2025 |
Listing of Color Additives Exempt From Certification; Myoglobin 2025-01239 | Final rule | Jan 17, 2025 |
Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments; Withdrawal 2025-01145 | Final rule | Jan 17, 2025 |
Expansion of Buprenorphine Treatment via Telemedicine Encounter 2025-01049 · significant | Final rule | Jan 17, 2025 |
Continuity of Care via Telemedicine for Veterans Affairs Patients 2025-01044 · significant | Final rule | Jan 17, 2025 |
Color Additive Petition From Center for Science in the Public Interest, et al.; Request To Revoke Color Additive Listing for Use of FD&C Red No. 3 in Food and Ingested Drugs 2025-00830 | Final rule | Jan 16, 2025 |
Food Labeling: Front-of-Package Nutrition Information 2025-00778 · significant | Proposed rule | Jan 16, 2025 |
Privacy Act; Implementation 2025-00670 | Final rule | Jan 16, 2025 |
Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels 2025-00425 | Final rule | Jan 16, 2025 |
Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products 2025-00397 | Proposed rule | Jan 16, 2025 |
Enhancing Coverage of Preventive Services Under the Affordable Care Act 2025-00774 | Proposed rule | Jan 15, 2025 |
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program 2025-00640 | Final rule | Jan 15, 2025 |
Parentage Establishment in the Child Support Services Program; Withdrawal 2025-00638 · significant | Proposed rule | Jan 15, 2025 |
Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program; Withdrawal 2025-00537 | Proposed rule | Jan 14, 2025 |
Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs, Including the Hospital Inpatient Quality Reporting Program; Health and Safety Standards for Obstetrical Services in Hospitals and Critical Access Hospitals; Prior Authorization; Requests for Information; Medicaid and CHIP Continuous Eligibility; Medicaid Clinic Services Four Walls Exceptions; Individuals Currently or Formerly in Custody of Penal Authorities; Revision to Medicare Special Enrollment Period for Formerly Incarcerated Individuals; and All-Inclusive Rate Add-On Payment for High-Cost Drugs Provided by Indian Health Service and Tribal Facilities; Correcting Amendment 2025-00081 | Final rule | Jan 13, 2025 |
Establishing Sanitation Programs for Low-Moisture Ready-To-Eat Human Foods and Taking Corrective Actions Following a Pathogen Contamination Event; Draft Guidance for Industry; Availability 2024-31528 | Proposed rule | Jan 7, 2025 |
Considerations for Complying With 21 CFR 211.110; Draft Guidance for Industry; Availability 2024-31356 | Final rule | Jan 6, 2025 |
HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information 2024-30983 · significant | Proposed rule | Jan 6, 2025 |
Uniform Compliance Date for Food Labeling Regulations 2024-31419 | Final rule | Dec 31, 2024 |
Name Change From Office of Child Support Enforcement to Office of Child Support Services 2024-30987 | Final rule | Dec 31, 2024 |
Coverage of Certain Preventive Services Under the Affordable Care Act 2024-31239 · significant | Proposed rule | Dec 30, 2024 |
Adoption and Foster Care Analysis and Reporting System; Correction 2024-31238 · significant | Final rule | Dec 30, 2024 |
Medicare Program: Appeal Rights for Certain Changes in Patient Status and Changes to the Medicare Claims and Medicare Prescription Drug Coverage Determination Appeals Procedures; Correcting Amendment 2024-31146 | Final rule | Dec 30, 2024 |
Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products 2024-30544 · significant | Proposed rule | Dec 27, 2024 |
Food Labeling: Nutrient Content Claims; Definition of Term “Healthy” 2024-29957 | Final rule | Dec 27, 2024 |
Investigations of Child Abuse and Neglect Rule; Correction 2024-30755 · significant | Final rule | Dec 26, 2024 |
Select Agent: Modified Junín Virus Vaccine Strain 2024-30568 | Final rule | Dec 26, 2024 |
Monterey Mushrooms, LLC; Filing of Food Additive Petition 2024-30362 | Proposed rule | Dec 26, 2024 |
Nonprescription Drug Product With an Additional Condition for Nonprescription Use 2024-30261 · significant | Final rule | Dec 26, 2024 |
Privacy Act; Implementation 2024-30311 | Final rule | Dec 23, 2024 |
Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies; Correction 2024-30169 | Final rule | Dec 20, 2024 |
Health Data, Technology, and Interoperability: Protecting Care Access 2024-29683 · significant | Final rule | Dec 17, 2024 |
Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins 2024-29583 · significant | Final rule | Dec 17, 2024 |
Health Data, Technology, and Interoperability: Trusted Exchange Framework and Common Agreement (TEFCA) 2024-29163 | Final rule | Dec 16, 2024 |
Administrative Simplification: Modifications of Health Insurance Portability and Accountability Act of 1996 (HIPAA) National Council for Prescription Drug Programs (NCPDP) Retail Pharmacy Standards; and Modification of the Medicaid Pharmacy Subrogation Standard 2024-29138 | Final rule | Dec 13, 2024 |
Employment and Training Services for Noncustodial Parents in the Child Support Program 2024-29081 · significant | Final rule | Dec 13, 2024 |
Leprino Nutrition; Filing of Food Additive Petition 2024-29248 | Proposed rule | Dec 12, 2024 |
Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly 2024-27939 · significant | Proposed rule | Dec 10, 2024 |
Clinical Trials Registration and Results Information Submission 2024-28475 | Final rule | Dec 9, 2024 |
Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments 2024-25382 · significant | Final rule | Dec 9, 2024 |
Adoption and Foster Care Analysis and Reporting System 2024-28072 · significant | Final rule | Dec 5, 2024 |
National Institute on Minority Health and Health Disparities Research Endowment Programs 2024-28082 | Final rule | Dec 4, 2024 |
Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model 2024-27841 · significant | Final rule | Dec 4, 2024 |
Final Scientific Integrity Policy; Withdrawal 2024-28128 | Final rule | Dec 2, 2024 |
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor 2024-28061 | Final rule | Dec 2, 2024 |
Health Care Programs: Fraud and Abuse; Revisions to the Office of Inspector General's Exclusion Authorities 2024-26804 | Proposed rule | Dec 2, 2024 |
Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts 2024-27710 | Proposed rule | Nov 27, 2024 |
Investigations of Child Abuse and Neglect Rule 2024-27626 · significant | Final rule | Nov 27, 2024 |
Organ Procurement and Transplantation: Implementation of the HIV Organ Policy Equity (HOPE) Act 2024-27410 | Final rule | Nov 27, 2024 |
Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs, Including the Hospital Inpatient Quality Reporting Program; Health and Safety Standards for Obstetrical Services in Hospitals and Critical Access Hospitals; Prior Authorization; Requests for Information; Medicaid and CHIP Continuous Eligibility; Medicaid Clinic Services Four Walls Exceptions; Individuals Currently or Formerly in Custody of Penal Authorities; Revision to Medicare Special Enrollment Period for Formerly Incarcerated Individuals; and All-Inclusive Rate Add-On Payment for High-Cost Drugs Provided by Indian Health Service and Tribal Facilities 2024-25521 | Final rule | Nov 27, 2024 |
Final Scientific Integrity Policy 2024-25810 | Final rule | Nov 25, 2024 |
Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications 2024-27018 · significant | Final rule | Nov 19, 2024 |
Increase Flexibility for Tribes in Child Care and Development Fund (CCDF) Eligibility 2024-26909 · significant | Final rule | Nov 18, 2024 |
Use of Federal Real Property To Assist the Homeless 2024-25722 · significant | Final rule | Nov 13, 2024 |
Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, Conditions for Coverage for End-Stage Renal Disease Facilities, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model 2024-25486 | Final rule | Nov 12, 2024 |
Color Additive Certification; Increase in Fees for Certification Services 2024-25974 · significant | Final rule | Nov 8, 2024 |
Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies 2024-25441 | Final rule | Nov 7, 2024 |
Head Start Program CLASS Implementation Date Delay 2024-25440 | Final rule | Nov 6, 2024 |
Supporting the Head Start Workforce and Consistent Quality Programming; Announcement and Correction 2024-23032 | Final rule | Oct 31, 2024 |
Indirect Food Additives: Adhesives and Components of Coatings; Paper and Paperboard Components; Polymers; Adjuvants, Production Aids, and Sanitizers 2024-25122 | Final rule | Oct 30, 2024 |
Environmental Defense Fund, et al.; Response to Objections and Requests for a Public Hearing 2024-25120 | Proposed rule | Oct 30, 2024 |
Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2025; Updating Section 1332 Waiver Public Notice Procedures; Medicaid; Consumer Operated and Oriented Plan (CO-OP) Program; and Basic Health Program; Correcting Amendment 2024-24910 | Final rule | Oct 28, 2024 |
New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address 2024-24820 | Final rule | Oct 28, 2024 |
Enhancing Coverage of Preventive Services Under the Affordable Care Act 2024-24675 | Proposed rule | Oct 28, 2024 |
Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally- Facilitated Exchanges, Merit-Based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program; Correcting Amendment 2024-24801 · significant | Final rule | Oct 25, 2024 |
Improving Child Care Access, Affordability, and Stability in the Child Care and Development Fund (CCDF); Corrections 2024-24781 | Final rule | Oct 25, 2024 |
Food and Drug Administration Enforcement Policy for Association of American Feed Control Officials-Defined Animal Feed Ingredients; Guidance for Industry; Availability 2024-24715 | Final rule | Oct 24, 2024 |
Department of Health and Human Services Policy for the Protection of Human Research Subjects: Update to the Additional Protections for Specific Populations 2024-24399 · significant | Final rule | Oct 24, 2024 |
Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments; Correction 2024-24100 | Final rule | Oct 18, 2024 |
Medical Devices; Quality System Regulation Amendments; Correction 2024-23701 | Final rule | Oct 15, 2024 |
Medicare Program: Appeal Rights for Certain Changes in Patient Status 2024-23195 · significant | Final rule | Oct 15, 2024 |
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2026; and Basic Health Program 2024-23103 | Proposed rule | Oct 10, 2024 |
Medicare Program; Changes to the Fiscal Year 2025 Hospital Inpatient Prospective Payment System (IPPS) Rates Due to Court Decision 2024-22765 | Final rule | Oct 3, 2024 |
HHS Acquisition Regulation: Regulatory Review 2024-17095 | Proposed rule | Oct 3, 2024 |
Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2025; Correction 2024-22504 | Final rule | Oct 2, 2024 |
Medicare and Medicaid Programs and the Children's Health Insurance Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2025 Rates; Quality Programs Requirements; and Other Policy Changes; Correction 2024-22501 | Final rule | Oct 2, 2024 |
Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2025 and Updates to the IRF Quality Reporting Program; Correction 2024-22497 | Final rule | Oct 2, 2024 |
Medicare Program; FY 2025 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update; Correction 2024-22496 · significant | Final rule | Oct 2, 2024 |
Health and Human Services Adoption of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards 2024-21984 | Final rule | Oct 2, 2024 |
Medicare Program; FY 2025 Hospice Wage Index and Payment Rate Update, Hospice Conditions of Participation Updates, and Hospice Quality Reporting Program Requirements; Correction 2024-22495 | Final rule | Oct 1, 2024 |
Medicare Program; Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2024-Remaining Provisions and Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (PACE); Correcting Amendment 2024-22203 · significant | Final rule | Sep 30, 2024 |
Medicare Program: Mitigating the Impact of Significant, Anomalous, and Highly Suspect Billing Activity on Medicare Shared Savings Program Financial Calculations in Calendar Year 2023 2024-22054 | Final rule | Sep 27, 2024 |
PHM Brands; Withdrawal of Food Additive Petition 2024-21934 | Proposed rule | Sep 26, 2024 |
Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program 2024-21254 | Final rule | Sep 26, 2024 |
Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices 2024-21932 | Proposed rule | Sep 25, 2024 |
Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption: What You Need To Know About the Food and Drug Administration Regulation; Small Entity Compliance Guide; Availability 2024-21840 | Final rule | Sep 24, 2024 |
DSM Biomedical; Filing of Color Additive Petition 2024-21684 | Proposed rule | Sep 23, 2024 |
Microbiology Devices; Reclassification of Cytomegalovirus Deoxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management 2024-21616 | Final rule | Sep 23, 2024 |
Requirements Related to the Mental Health Parity and Addiction Equity Act 2024-20612 | Final rule | Sep 23, 2024 |
Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and The European Community 2024-21559 | Proposed rule | Sep 20, 2024 |
Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments 2024-21232 | Proposed rule | Sep 20, 2024 |
Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments 2024-21231 | Final rule | Sep 20, 2024 |
Performance Standards for Medicaid Fraud Control Units 2024-20416 | Final rule | Sep 18, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Quantitative Viral Nucleic Acid Test for Transplant Patient Management 2024-21086 | Final rule | Sep 17, 2024 |
Public Health Service Policies on Research Misconduct 2024-20814 | Final rule | Sep 17, 2024 |
Medical Devices; Therapeutic Devices; Classification of the Pediatric Continuous Renal Replacement Therapy System 2024-20999 | Final rule | Sep 16, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers 2024-20896 | Final rule | Sep 16, 2024 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Clozapine Test System 2024-20895 | Final rule | Sep 16, 2024 |
Enforcement Policy for Required Warnings for Cigarette Packages and Advertisements; Guidance for Industry; Availability 2024-20850 | Final rule | Sep 13, 2024 |
Organ Procurement and Transplantation: Implementation of the HIV Organ Policy Equity (HOPE) Act 2024-20643 | Proposed rule | Sep 12, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Whole Exome Sequencing Constituent Device 2024-20550 | Final rule | Sep 11, 2024 |
World Trade Center (WTC) Health Program; Expanded Eligibility for Pentagon and Shanksville, Pennsylvania Responders 2024-20540 | Final rule | Sep 11, 2024 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Blood Collection Device for Cell-Free Nucleic Acids 2024-20254 | Final rule | Sep 9, 2024 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Pancreatic Debridement Device 2024-20248 | Final rule | Sep 9, 2024 |
Medicare Program; Medicare Prescription Drug Benefit Program; Health Information Technology Standards and Implementation Specifications; Correction 2024-20174 | Final rule | Sep 9, 2024 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Hemodialyzer With Expanded Solute Removal Profile 2024-20081 | Final rule | Sep 6, 2024 |
Medical Devices; Ophthalmic Devices; Classification of the Hydrophilic Re-Coating Solution 2024-19882 | Final rule | Sep 5, 2024 |
Medical Devices; Dental Devices; Classification of the Radiofrequency Toothbrush 2024-19868 | Final rule | Sep 5, 2024 |
Food Additives Permitted in Feed and Drinking Water of Animals; Pichia Pastoris Dried Yeast 2024-19856 | Final rule | Sep 5, 2024 |
Medical Devices; Hematology and Pathology Devices; Classification of the Heparin and Direct Oral Factor Xa Inhibitor Drug Test System 2024-19824 | Final rule | Sep 5, 2024 |
Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Open Loop Fluid Therapy Recommender 2024-19736 | Final rule | Sep 5, 2024 |
Medical Devices; Orthopedic Devices; Classification of the Intervertebral Body Graft Containment Device 2024-19726 | Final rule | Sep 3, 2024 |
Medical Devices; Dental Devices; Classification of the Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea 2024-19725 | Final rule | Sep 3, 2024 |
Medical Devices; Physical Medicine Devices; Classification of the External Compression Device for Internal Jugular Vein Compression 2024-19722 | Final rule | Sep 3, 2024 |
Medical Devices; Neurological Devices; Classification of the Digital Therapy Device for Attention Deficit Hyperactivity Disorder 2024-19720 | Final rule | Sep 3, 2024 |
Prohibition of Sale of Tobacco Products to Persons Younger Than 21 Years of Age 2024-19481 · significant | Final rule | Aug 30, 2024 |
Catastrophic Health Emergency Fund 2024-19421 | Final rule | Aug 30, 2024 |